Nano-Mod-Amp reveals RNA sequence, structural and cell type specific features of pseudouridylation by PUS7
Authors:
- Rebecca RodellRRRebecca Rodell
- Ronit JainRJRonit Jain
- Hossein ShenasaHSHossein Shenasa
- Matias MontesMMMatias Montes
- Nicolas RobalinNRNicolas Robalin
- Stefan ProdicSPStefan Prodic
- Eduardo EyrasEEEduardo Eyras
- Nicole M. MartinezNMNicole M. Martinez
Preprint
Abstract
Pseudouridines are abundant mRNA modifications that can impact splicing, translation, and stability to tune gene expression. PUS7 is one of the major mRNA pseudouridine synthase whose dysregulation leads to neurodevelopmental disorders and cancer, underscoring the critical function of PUS7-dependent pseudouridines. Beyond a short and degenerate consensus sequence, the molecular mechanisms underlying PUS7-mediated pseudouridylation remain unknown. A lack of targeted, high-throughput pseudouridine detection methods limits simultaneous interrogation of PUS7 regulatory features across many experimental conditions. We developed novel Nanopore sequencing tools, including Nano-Mod-Amp, to reveal pseudouridine stoichiometry, its RNA structural context, and dependence on PUS7 levels at specific sites across biological conditions. We identified a novel RNA structural signature that is associated with more efficient mRNA modification by PUS7. Pseudouridines are largely responsive to modulations in PUS7 protein levels, demonstrating the regulatory potential of varying PUS7 levels across cellular conditions. Conversely, PUS7 activity is also regulated in a cell-type specific manner, independent of PUS7 expression levels in a manner consistent with regulation by RNA structure and RNA binding proteins. Together, we developed Nanopore sequencing tools and uncovered new mechanisms of PUS7 regulation with a framework that can be applied to other RNA-modifying enzymes to query the regulation of the epitranscriptome. Highlights: Nanopore direct RNA sequencing identifies PUS7-dependent pseudouridines with stoichiometry. Nano-Mod-Amp quantifies PUS7-dependent pseudouridines at hundreds of sites in high-throughput. MPRAs define RNA sequence and structural features associated with modification by PUS7. Individual PUS7 target pseudouridines are substoichiometric and poised for regulation. PUS7 activity is regulated by cell type in the absence of differences in PUS7 protein levels.Keywords
Funding Information
- National Institute of General Medical Sciences (R00 GM135537)
- National Institute of General Medical Sciences (T32GM136631)
This publication has 61 references indexed in Scilit:
- A PUS7 gene pathogenic variant causing self‐injurious behavior, sleep disturbances, and developmental delay: A case reportAmerican Journal of Medical Genetics Part A, 2023
- Pseudouridine site assignment by high-throughput in vitro RNA pseudouridylation and sequencing2021
- Investigating Pseudouridylation Mechanisms by High-Throughput in Vitro RNA Pseudouridylation and Sequencing2021
- PUS7 mutations impair pseudouridylation in humans and cause intellectual disability and microcephalyHuman Genetics, 2019
- Variants in PUS7 Cause Intellectual Disability with Speech Delay, Microcephaly, Short Stature, and Aggressive BehaviorThe American Journal of Human Genetics, 2018
- Dynamic RNA Modifications in Gene Expression RegulationCell, 2017
- A Highly Conserved Program of Neuronal Microexons Is Misregulated in Autistic BrainsCell, 2014
- Transcriptome-wide Mapping Reveals Widespread Dynamic-Regulated Pseudouridylation of ncRNA and mRNACell, 2014
- Direct Competition between hnRNP C and U2AF65 Protects the Transcriptome from the Exonization of Alu ElementsCell, 2013
- Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop CodonsCell, 2012